Pancreatic Cancer - Pipeline Review, H2 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Pancreatic Cancer - Pipeline Review, H2 2016" report to their offering.

Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Predisposing factors include age, gender, smoking, diabetes and family history. Treatment includes surgery, chemotherapy and radiation therapy.

This report provides comprehensive information on the therapeutic development for Pancreatic Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pancreatic Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned

  • 3M Drug Delivery Systems
  • 4SC AG
  • AB Science SA
  • AbbVie Inc
  • AbGenomics International Inc
  • ATLAB Pharma SAS
  • Aurigene Discovery Technologies Ltd
  • AVEO Pharmaceuticals Inc
  • Axcentua Pharmaceuticals AB
  • Azaya Therapeutics Inc
  • Basilea Pharmaceutica Ltd
  • Bavarian Nordic A/S
  • Bayer AG
  • BeiGene Ltd
  • Critical Outcome Technologies Inc
  • CrystalGenomics Inc
  • CTI BioPharma Corp
  • (200+ Others)

Key Topics Covered:

  1. Introduction
  2. Pancreatic Cancer Overview
  3. Therapeutics Development
  4. Pipeline Products for Pancreatic Cancer - Overview
  5. Pipeline Products for Pancreatic Cancer - Comparative Analysis
  6. Pancreatic Cancer - Therapeutics under Development by Companies
  7. Pancreatic Cancer - Therapeutics under Investigation by Universities/Institutes
  8. Pancreatic Cancer - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Pancreatic Cancer - Products under Development by Companies
  13. Pancreatic Cancer - Products under Investigation by Universities/Institutes
  14. Pancreatic Cancer - Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/ps8tg6/pancreatic_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pancreatic Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pancreatic Cancer Drugs